Update on review of valsartan medicines due to detection of NDMA
10/08/2018 Update on review of valsartan medicines due to detection of NDMA EMA reviewing valsartan produced by another company Zhejiang Tianyu As part of the ongoing review of valsartan medicines, EMA has learnt that low levels of N-nitrosodimethylami… read more